Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Huntington SF"'
Autor:
Orellana-Noia, VM, Reed, DR, McCook, AA, Sen, JM, Barlow, CM, Malecek, M-K, Watkins, M, Kahl, BS, Spinner, MA, Advani, R, Voorhees, TJ, Snow, A, Grover, NS, Ayers, A, Romancik, JT, Liu, Y, Huntington, SF, Chavez, JC, Saeed, H, Lazaryan, A, Raghunathan, V, Spurgeon, SE, Ollila, TA, Del Prete, C, Olszewski, AJ, Ayers, EC, Landsburg, DJ, Echalier, B, Lee, J, Kamdar, M, Caimi, PF, Fu, T, Liu, J, David, KA, Alharthy, H, Law, J, Karmali, R, Shah, H, Stephens, DM, Major, A, Rojek, AE, Smith, SM, Yellala, A, Kallam, A, Nakhoda, S, Khan, N, Sohail, MA, Hill, BT, Barrett-Campbell, O, Lansigan, F, Switchenko, J, Cohen, JB, Portell, CA
Publikováno v:
Blood; 20210101, Issue: Preprints
Autor:
Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT., Manzoor BS; AbbVie Inc., North Chicago, IL., Jawaid D; AbbVie Inc., North Chicago, IL., Puckett JT; COVIA Health Solutions, Ambler, PA., Emechebe N; AbbVie Inc., North Chicago, IL., Ravelo A; Genentech Inc., South San Francisco, CA., Kamal-Bahl S; COVIA Health Solutions, Ambler, PA., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Oct; Vol. 30 (10), pp. 1106-1116. Date of Electronic Publication: 2024 Jul 24.
Autor:
Squires P; Merck & Co, Inc, Rahway, NJ., Puckett J; COVIA Health Solutions, Lansdale, PA. Electronic address: justin@coviahealthsolutions.com., Ryland KE; Merck & Co, Inc, Rahway, NJ., Kamal-Bahl S; COVIA Health Solutions, Lansdale, PA. Electronic address: sachin@coviahealthsolutions.com., Raut M; Merck & Co, Inc, Rahway, NJ., Doshi J; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Oct; Vol. 24 (10), pp. e350-e358.e1. Date of Electronic Publication: 2024 Jun 04.
Autor:
Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Patel KK; Department of Medicine, Brigham and Women's Hospital, Boston, MA., Shallis RM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT., Podoltsev NA; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT., Kewan T; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Stempel J; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Mendez L; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT., Stahl M; Department of Medical Oncology, Adult Leukemia Program, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA., Stein EM; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Huntington SF; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale University, New Haven, CT., Goshua G; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT., Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Department of Medical Oncology, Adult Leukemia Program, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Aug; Vol. 65 (8), pp. 1136-1144. Date of Electronic Publication: 2024 Apr 22.
Autor:
Di M; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale University, New Haven, CT, USA.; Division of Hematology and Oncology, Department of Medicine, University of Washington/Fred Hutchinson Cancer Center, Seattle, WA, USA., Potnis KC; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Long JB; Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale University, New Haven, CT, USA., Isufi I; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Foss F; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Seropian S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA., Gross CP; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale University, New Haven, CT, USA., Huntington SF; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.; Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale University, New Haven, CT, USA.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Jul 01; Vol. 8 (4).
Autor:
Huntington SF; Yale School of Medicine, New Haven, CT, USA., Cheng WY; Analysis Group, Inc, Boston, MA, USA., Sarpong EM; Merck & Co., Inc, Rahway, NJ, USA., Leng S; Merck & Co., Inc, Rahway, NJ, USA., Farooqui MZH; Merck & Co., Inc, Rahway, NJ, USA., Agu US; University of Arizona, Tucson, AZ, USA., Catillon M; Analysis Group, Inc, Boston, MA, USA., Lejeune D; Groupe d'analyse, Ltée, Montréal, QC, Canada., Downes N; Analysis Group, Inc, Boston, MA, USA., Matay L; Analysis Group, Inc, Boston, MA, USA., Duh MS; Analysis Group, Inc, Boston, MA, USA., De Nigris E; MSD (UK) Limited, London, UK.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Jul; Vol. 65 (7), pp. 932-942. Date of Electronic Publication: 2024 May 02.
Autor:
Garg M; Merck & Co., Inc., Rahway, NJ., Puckett J; COVIA Health Solutions, PA., Kamal-Bahl S; COVIA Health Solutions, PA. Electronic address: sachin@coviahealthsolutions.com., Raut M; Merck & Co., Inc., Rahway, NJ., Ryland KE; Merck & Co., Inc., Rahway, NJ., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 May; Vol. 24 (5), pp. e181-e190. Date of Electronic Publication: 2024 Feb 09.
Autor:
Garg M; Merck & Co., Inc., Rahway, NJ 07065, USA., Puckett J; COVIA Health Solutions, Lansdale, PA 19446, USA., Kamal-Bahl S; COVIA Health Solutions, Lansdale, PA 19446, USA., Raut M; Merck & Co., Inc., Rahway, NJ 07065, USA., Ryland KE; Merck & Co., Inc., Rahway, NJ 07065, USA., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT 06510, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Feb; Vol. 20 (6), pp. 317-328. Date of Electronic Publication: 2023 Dec 05.
Autor:
Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, Connecticut, USA., de Nigris E; MSD (UK) Limited, London, UK., Puckett JT; COVIA Health Solutions, Ambler, Pennsylvania, USA., Kamal-Bahl S; COVIA Health Solutions, Ambler, Pennsylvania, USA., Farooqui M; Merck & Co., Inc, Rahway, New Jersey, USA., Ryland K; Merck & Co., Inc, Rahway, New Jersey, USA., Sarpong EM; Merck & Co., Inc, Rahway, New Jersey, USA., Leng S; Merck & Co., Inc, Rahway, New Jersey, USA., Yang X; Merck & Co., Inc, Rahway, New Jersey, USA., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Jan; Vol. 13 (2), pp. e6953.
Autor:
Huntington SF; Department of Internal Medicine, Section of Hematology, Yale University, New Haven, CT, USA., Manzoor BS; AbbVie Inc, North Chicago, IL, USA., Puckett JT; COVIA Health Solutions, Lansdale, PA, USA., Kamal-Bahl S; COVIA Health Solutions, Lansdale, PA, USA., Alhasani H; AbbVie Inc, North Chicago, IL, USA., Ravelo A; Genentech Inc, South San Francisco, CA, USA., Jawaid D; AbbVie Inc, North Chicago, IL, USA., Doshi JA; Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Dec; Vol. 64 (14), pp. 2316-2323. Date of Electronic Publication: 2023 Dec 25.